APO 250-125 (Amoxicillin and Clavulanate 250 mg / 125 mg)
Pill imprint APO 250-125 has been identified as Amoxicillin and clavulanate potassium 250 mg / 125 mg.
Amoxicillin/clavulanate is used in the treatment of bacterial infection; sinusitis; urinary tract infection; skin or soft tissue infection; bronchiectasis (and more), and belongs to the drug class beta-lactamase inhibitors. There is no proven risk in humans during pregnancy. Amoxicillin/clavulanate 250 mg / 125 mg is not a controlled substance under the Controlled Substance Act (CSA).
- APO 250-125
- 250 mg / 125 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Beta-lactamase inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Apotex Corp.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
polyethylene glycol 8000
More about amoxicillin/clavulanate
- Amoxicillin and Clavulanate
- Amoxicillin/clavulanate chewable tablets
- Amoxicillin/clavulanate extended-release tablets
- Amoxicillin/clavulanate suspension
- More (2) »
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.